Equity
Total Liabilities & Equity
Amgen Total Liabilities & Equity increased by 2.1% to $92.50B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.5%, from $89.37B to $92.50B. Over 5 years (FY 2020 to FY 2025), Total Liabilities & Equity shows an upward trend with a 7.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryLeverage
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Growth in this metric typically reflects business expansion, though it must be analyzed alongside asset quality to determine if it stems from debt or equity financing.
Detailed definition
This metric represents the sum of all financial obligations and shareholder equity, which must equal the total assets of...
Peer comparison
Used by analysts to compare the overall scale and capital intensity of companies within the same industry.
Metric ID:
total_liabilities_and_equityHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $59.77B | $64.99B | $61.17B | $59.20B | $59.29B | $63.70B | $65.12B | $88.72B | $90.27B | $90.53B | $97.15B | $92.98B | $90.91B | $90.88B | $91.84B | $89.37B | $87.90B | $90.14B | $90.59B | $92.50B |
| QoQ Change | — | +8.7% | -5.9% | -3.2% | +0.2% | +7.4% | +2.2% | +36.2% | +1.7% | +0.3% | +7.3% | -4.3% | -2.2% | -0.0% | +1.1% | -2.7% | -1.6% | +2.6% | +0.5% | +2.1% |
| YoY Change | — | — | — | — | -0.8% | -2.0% | +6.5% | +49.9% | +52.2% | +42.1% | +49.2% | +4.8% | +0.7% | +0.4% | -5.5% | -3.9% | -3.3% | -0.8% | -1.4% | +3.5% |
Range$59.20B – $97.15B
CAGR+9.6%
Avg YoY Growth+12.0%
Median YoY Growth+0.5%
Current Streak3 quarters growth
Total Liabilities & Equity at Other Companies
Frequently Asked Questions
- What is Amgen's total liabilities & equity?
- Amgen (AMGN) reported total liabilities & equity of $92.50B in Q1 2026.
- How has Amgen's total liabilities & equity changed year-over-year?
- Amgen's total liabilities & equity increased by 3.5% year-over-year, from $89.37B to $92.50B.
- What is the long-term trend for Amgen's total liabilities & equity?
- Over 5 years (2020 to 2025), Amgen's total liabilities & equity has grown at a 7.6% compound annual growth rate (CAGR), from $62.95B to $90.59B.
- What does total liabilities & equity mean?
- The total size of the company's balance sheet, representing the sum of all funding sources.